Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Immunoprecise Antibodies stock

Learn how to easily invest in Immunoprecise Antibodies stock.

Immunoprecise Antibodies Ltd is a biotechnology business based in the US. Immunoprecise Antibodies shares (IPA) are listed on the NASDAQ and all prices are listed in US Dollars. Immunoprecise Antibodies employs 73 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Immunoprecise Antibodies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IPA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Immunoprecise Antibodies stock price (NASDAQ: IPA)

Use our graph to track the performance of IPA stocks over time.

Immunoprecise Antibodies shares at a glance

Information last updated 2022-07-01.
Latest market close$3.95
52-week range$3.51 - $16.47
50-day moving average $4.91
200-day moving average $5.44
Wall St. target price$12.05
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.69

Buy Immunoprecise Antibodies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Immunoprecise Antibodies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Immunoprecise Antibodies price performance over time

Historical closes compared with the close of $3.95 from 2022-07-05

1 week (2022-06-30) 3.95%
1 month (2022-06-06) -27.52%
3 months (2022-04-07) -28.44%
6 months (2022-01-06) -34.06%
1 year (2021-07-07) -33.39%
2 years (2020-07-07) 329.35%
3 years (2019-07-05) 642.48%
5 years (2017-07-05) 353.29%

Immunoprecise Antibodies financials

Revenue TTM $19 million
Gross profit TTM $11.4 million
Return on assets TTM -18.66%
Return on equity TTM -42.77%
Profit margin -89.98%
Book value $2.45
Market capitalisation $90.4 million

TTM: trailing 12 months

Immunoprecise Antibodies share dividends

We're not expecting Immunoprecise Antibodies to pay a dividend over the next 12 months.

You may also wish to consider:

Have Immunoprecise Antibodies's shares ever split?

Immunoprecise Antibodies's shares were split on a 1:5 basis on 22 November 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Immunoprecise Antibodies shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Immunoprecise Antibodies shares which in turn could have impacted Immunoprecise Antibodies's share price.

Immunoprecise Antibodies share price volatility

Over the last 12 months, Immunoprecise Antibodies's shares have ranged in value from as little as $3.51 up to $16.47. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immunoprecise Antibodies's is -0.2276. This would suggest that Immunoprecise Antibodies's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Immunoprecise Antibodies has bucked the trend.

To put Immunoprecise Antibodies's beta into context you can compare it against those of similar companies.

Immunoprecise Antibodies overview

ImmunoPrecise Antibodies Ltd. , together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S. A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03.

Frequently asked questions

What percentage of Immunoprecise Antibodies is owned by insiders or institutions?
Currently 5.905% of Immunoprecise Antibodies shares are held by insiders and 5.344% by institutions.
How many people work for Immunoprecise Antibodies?
Latest data suggests 73 work at Immunoprecise Antibodies.
When does the fiscal year end for Immunoprecise Antibodies?
Immunoprecise Antibodies's fiscal year ends in April.
Where is Immunoprecise Antibodies based?
Immunoprecise Antibodies's address is: 3204?4464 Markham Street, Victoria, BC, Canada, V8Z 7X8
What is Immunoprecise Antibodies's ISIN number?
Immunoprecise Antibodies's international securities identification number is: CA45257F2008

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site